Literature DB >> 12048078

Randomized comparative study of radial artery and right gastroepiploic artery in composite arterial graft for CABG.

G G Santos1, N A G Stolf, L F P Moreira, V L S Haddad, R M C Simões, S R V Carvalho, A A Salgado, S F Avelar.   

Abstract

OBJECTIVES: Arterial grafts have been used to achieve better long-term results and improve graft patency in coronary artery bypass grafting. Composite graft was proposed to overcome inconveniences of proximal anastomoses to the aorta and increase the use and surgical options of arterial grafts. However, lack of prospective randomized studies with this kind of grafts is evident. We compare the results of composite Y-grafts of the radial artery (RA) and the right gastroepiploic artery (RGEA) proximally anastomosed to the left internal thoracic artery (LITA) for CABG, evaluated through angiography, in a prospective randomized study.
METHODS: Between August 1998 and November 1999, 60 patients were randomly divided into two groups: group I (GI) received RGEA graft and group II (GII), RA graft. LITA was used to graft the left anterior descending artery and RGEA or RA was placed to obtuse marginal or first diagonal branch. The right coronary artery branches was grafted with saphenous vein graft (SVG) when necessary. All coronary arteries receiving arterial grafts had > or =75% proximal stenosis and diameter > or =1.5 mm.
RESULTS: GI and GII preoperative data were similar, 63 distal anastomoses were performed with the LITA, 32 with the RA and 32 with the RGEA. There were two perioperative deaths (3.3%), one in each group, none related to cardiac causes. Four (6.6%) q-wave myocardial infarctions were found and two (3.3%) patients showed low cardiac output syndrome. Angiography was performed in all surviving patients from the 8th to 15th postoperative day and showed a patency rate of 96.5% (56/58) for LITA, 89.6% (26/29) for RA and 68.9% (20/29) for RGEA, with a statistically significant difference between RGEA and RA (P=0.025).
CONCLUSIONS: Radial artery had better early results than right gastroepiploic artery. Use of the LITA as inflow graft seems not to affect its good patency. Use of the RGEA as composite graft should not be encouraged. Long-term follow-up with objective investigation and randomized trials is required to confirm better results of composite conduits.

Entities:  

Mesh:

Year:  2002        PMID: 12048078     DOI: 10.1016/s1010-7940(02)00180-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Systematic comparison of the effectiveness of radial artery and saphenous vein or right internal thoracic artery coronary bypass grafts in non-left anterior descending coronary arteries.

Authors:  Xiang Hu; Qiang Zhao
Journal:  J Zhejiang Univ Sci B       Date:  2011-04       Impact factor: 3.066

2.  Redo off-pump coronary bypass grafting with arterial grafts for Kawasaki disease.

Authors:  Kaoru Matsuura; Junjiro Kobayashi; Ko Bando; Kazuo Niwaya; Osamu Tagusari; Hiroyuki Nakajima; Soichiro Kitamura
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

3.  Angiographic Patency of Coronary Artery Bypass Conduits: A Network Meta-Analysis of Randomized Trials.

Authors:  Mario Gaudino; Irbaz Hameed; N Bryce Robinson; Yongle Ruan; Mohamed Rahouma; Ajita Naik; Viola Weidenmann; Michelle Demetres; Derrick Y Tam; David L Hare; Leonard N Girardi; Giuseppe Biondi-Zoccai; Stephen E Fremes
Journal:  J Am Heart Assoc       Date:  2021-03-09       Impact factor: 5.501

4.  Evidence-based selection of the second and third arterial conduit.

Authors:  Taylor Gillmore; Rodolfo V Rocha; Stephen E Fremes
Journal:  JTCVS Open       Date:  2020-11-25

Review 5.  Total Arterial Revascularization: Bypassing Antiquated Notions to Better Alternatives for Coronary Artery Disease.

Authors:  Mostafa Samak; Javid Fatullayev; Anton Sabashnikov; Mohamed Zeriouh; Bastian Schmack; Arjang Ruhparwar; Matthias Karck; Aron-Frederik Popov; Pascal M Dohmen; Alexander Weymann
Journal:  Med Sci Monit Basic Res       Date:  2016-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.